MARKET WIRE NEWS
  1. Home
  2. Stock
  3. BMRN
  4. News
BMRN
Quote
Short
News
Articles
Message Board

BioMarin Pharmaceutical Inc. (NASDAQ : BMRN ) News

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) News Releases

BMRN News Releases
BMRN : NASDAQ
SeekingAlpha
BioMarin Pharmaceutical Inc. (BMRN) Presents at TD Cowen 46th Annual Health Care Conference Transcript
BMRN : NASDAQ
SeekingAlpha
Ascendis Pharma: Yuviwel Approved Despite Legal Challenges
BMRN : NASDAQ
KlickAnalytics
BMRN Price Target Alert: $105.00. Issued by Barclays
BMRN : NASDAQ
KlickAnalytics
BMRN Price Target Alert: $105.00. Issued by Loop Capital Markets
BMRN : NASDAQ
PR Newswire
U.S. Food and Drug Administration Approves BioMarin's PALYNZIQ® (pegvaliase-pqpz) for Adolescents 12 Years of Age and Older with Phenylketonuria (PKU)
BMRN : NASDAQ
PR Newswire
BioMarin to Participate in Four Upcoming Investor Conferences in March
BMRN : NASDAQ
SeekingAlpha
BioMarin signals $3.325B-$3.425B 2026 revenue target as acquisitions and pipeline drive growth
BMRN : NASDAQ
SeekingAlpha
BioMarin Pharmaceutical Inc. (BMRN) Q4 2025 Earnings Call Transcript
BMRN : NASDAQ
SeekingAlpha
BioMarin Pharmaceutical Non-GAAP EPS of $0.46 misses by $0.10, revenue of $875M beats by $39.97M
BMRN : NASDAQ
PR Newswire
BioMarin Reports Fourth Quarter and Full-year 2025 Financial and Operating Results

Subscribe to Our Newsletter

Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.

Download The Market Wire News App

Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.

Market Wire News iPhone App Market Wire News Android App

Link Market Wire News to Your X Account

Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.